Azenta, Inc. AZTA

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $33.38
Market Cap $1.56B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-9.5% YoY
$593.82M
3-Yr CAGR: 2.2%
Net Income ↑66.0% YoY
-$55.76M
Net Margin: -9.4%
Free Cash Flow ↑197.2% YoY
$38.32M
FCF Yield: 2.45%
EPS (Diluted) ↑60.5% YoY
$-1.22
Basic: $-1.22
Return on Equity Efficiency
-3.3%
ROA: -83.0%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (AZTA)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $560.3M $198.1M $-69.5M $-1.01 $39.5M $26.7M
FY 2017 $692.9M +23.7% $267.4M $62.6M +190.1% $0.89 +188.1% $96.2M $83.5M +212.9%
FY 2018 $631.6M -8.9% $246.1M $116.6M +86.2% $1.64 +84.3% $74.0M $61.2M -26.8%
FY 2019 $780.8M +23.6% $316.3M $437.4M +275.2% $6.04 +268.3% $90.9M $67.0M +9.6%
FY 2020 $897.3M +14.9% $380.0M $64.9M -85.2% $0.88 -85.4% $37.9M $-2.1M -103.1%
FY 2021 $513.7M -42.7% $243.8M $110.7M +70.8% $1.49 +69.3% $149.9M $97.1M +4,815.8%
FY 2022 $555.5M +8.1% $255.6M $2,132.9M +1,825.9% $28.48 +1,811.4% $-466.0M $-539.5M -655.9%
FY 2023 $665.1M +19.7% $263.1M $-14.3M -100.7% $-0.22 -100.8% $17.5M $-21.9M +95.9%
FY 2024 $656.3M -1.3% $263.4M $-164.2M -1,051.5% $-3.09 -1,304.5% $50.3M $12.9M +158.8%
FY 2025 $593.8M -9.5% $270.3M $-55.8M +66.0% $-1.22 +60.5% $72.2M $38.3M +197.2%
$

Valuation

Market Price $33.38
Market Cap $1.56B
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio 0.91
FCF Yield 2.45%
Dividend Yield -3.66%
Shares Outstanding 46,092,800
%

Profitability & Margins

Gross Margin 45.52%
Operating Margin -4.52%
Net Margin -9.39%
Return on Equity (ROE) -3.29%
Return on Assets (ROA) -82.96%
Asset Turnover 8.83x
Revenue 3-Yr CAGR 2.25%
🛡️

Financial Health & Liquidity

Current Ratio 0.30
Cash Ratio 1.41
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $310.93M
Total Debt N/A
Book Value / Share $36.78
💧

Cash Flow Efficiency

Operating Cash Flow $72.18M
Capital Expenditures (CapEx) $33.86M
Free Cash Flow $38.32M
OCF / Revenue 12.16%
FCF / Revenue 6.45%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-1.22
EPS (Basic) $-1.22
Dividends / Share $-1.22
Book Value / Share $36.78
EPS YoY Growth 60.52%
🏛️

Balance Sheet (FY 2025)

Total Assets $67.21M
Total Liabilities $221.05M
Stockholders' Equity $1.70B
Current Assets $67.21M
Current Liabilities $221.05M